InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by Adrian Kinkaid. Director active across 1 company, notably Fusion Antibodies plc. Cumulatively, 4 filings have been recorded. History available since 4 December 2023. The latest transaction was disclosed on 6 May 2025 (Purchase). Regulator: RNS (LSE). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Adrian Kinkaid is a declarant linked to Fusion Antibodies plc, where he holds the role of Chief Executive Officer. He has 4 filings in total, and across the 4 most recent filings we hold, these were purchases totaling EUR 21805, between 2023-12-04 and 2025-05-06.